Regulating human genetics: The changing politics of biotechnology governance in the European Union

Health, Risk and Society

Volumn 4, Issue 3, 2002, Pages 325-340

  Salter, Brian ^a   Jones, Mavis ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Europe; GM; Governance; Innovative health technology; Regulation; Risk

Indexed keywords

ARTICLE; BIOTECHNOLOGY; COMMUNITY; COMPETITION; CONTROLLED STUDY; CROP; EUROPEAN UNION; GOVERNMENT; HUMAN; HUMAN GENETICS; INDUSTRY; MANAGEMENT; MEDICAL TECHNOLOGY; NON PROFIT ORGANIZATION; POLICY; POLITICS; SOCIETY;

EID: 0036828176     PISSN: 13698575     EISSN: None     Source Type: Journal    
DOI: 10.1080/1369857021000016669     Document Type: Article

References (60)

1. ABELS, G. (1998) The European Community as an ethical actor? Policy making on the human genome and the role of the European Parliament, in: P. WHEALE, R. VON SCHOMBERG and P. GLASNER (Eds) The Social Management of Genetic Engineering, pp. 45-62 (Aldershot, Ashgate).
2. ABRAHAM, J. (1997) The science and politics of medicines regulation, in: M.A. ELSTON (Ed.) The Sociology of Medical Science and Technology (Oxford, Blackwell Publishers).
3. ABRAHAM, J. and LEWIS, G. (1999) Harmonising and competing for medicine's regulation: how healthy are the European Union's systems of drug approval, Social Science and Medicine, 48, pp. 1655-1667.
4. ABRAHAM, J. and LEWIS, G. (2000) Regulating Medicines in Europe (London, Routledge).
5. AGRAFOOD BIOTECH (2001) Coleman: EFA will help build public trust in GMOs', Agrafood Biotech, No. 68, 13 November, p. 5.
6. BECK, U. (1992) Risk Society: Towards a New Modernity (London, Sage).
7. BRUGNOLI, P., BARCIA, I. and LOMBARDINI, M. (2001) Comparative Study Concerning National, European and International Legislation in the Area of Human Genetics, Project report for the European Parliament's Temporary Committee on Human Genetics, Brussels.
8. CUTLER, C., HAUFLER, V. and PORTER, T. (Eds) (1999) Private Authority and International Affairs (New York, SUNY Press).
9. EUROPEAN COMMISSION (2000) On the Precautionary Principle, COM(2000)1, Brussels.
10. EUROPEAN COMMISSION (2001a) White Paper on European Governance, COM(2001) 428 Final of 25.7.2001, Brussels.
11. EUROPEAN COMMISSION (2001b) Towards a Strategic Vision of Life Sciences and Biotechnology, COM(2001) 454 Final of 4.9.2001, Brussels.
12. EUROPEAN COMMISSION (2001c) Proposal for a Decision of the EP and of the Council Concerning the Multiannual Framework Programme 2002-2006 of the European Community for Research, Technological Development and Demonstration Activities, COM(2001)94, Brussels.
13. EUROPEAN COMMISSION (2002a) Amended Proposals for Council Decision Concern the Specific Programmes Implementing the 6th Framework Programme of the European Community for Research, Technological Development and Demonstration Activities 2002-2006, COM(2002)43 Final of 30.22.2002, Brussels.
14. EUROPEAN COMMISSION (2002b) Life Sciences and Biotechnology-A Strategy for Europe COM(2002)27 Final, Brussels.
15. EUROPEAN COUNCIL (1999) Council Decision 1999/167/EC adopting a Specific Programme for Research, Technological Development and Demonstration on Quality of Life and Management of Living Resources, 1998-2002, Official Journal. L 64, 12/3/1999, pp. 1-19.
16. EUROPEAN GROUP ON ETHICS IN SCIENCE AND NEW TECHNOLOGIES (EGE) (1998) Ethical Aspects of Research Involving the Use of Human Embryos in the Context of the 5th Framework Programme, Opinion No. 12 to the European Commission.
17. EUROPEAN GROUP ON ETHICS IN SCIENCE AND NEW TECHNOLOGIES (EGE) (2000) Citizen Rights and New Technologies: a European Challenge, Brussels, available at .
18. EUROPEAN GROUP ON ETHICS IN SCIENCE AND NEW TECHNOLOGIES (EGE) (2001) General Report of the Activities of the European Group on Ethics, 1998-2000, Brussels.
19. EUROPEAN PARLIAMENT (1989) Resolution on the ethical and legal problems of genetic engineering, Official Journal, C 096, 17/4/1989, p. 171.
20. EUROPEAN PARLIAMENT (1993) Resolution on the cloning of the human embryo, Official Journal C 315, 22/11/1993, p. 224.
21. EUROPEAN PARLIAMENT (1997) Resolution on the cloning of human beings, Official Journal C 115, 14/4/1997, p. 92.
22. EUROPEAN PARLIAMENT (1998) Resolution on the cloning of human beings, Official Journal C 034, 2/2/1998, p. 164.
23. EUROPEAN PARLIAMENT (2000) Resolution on the cloning of human beings (September).
24. EUROPEAN PARLIAMENT (2001a) .
25. EUROPEAN PARLIAMENT AND THE COUNCIL OF EUROPE (1998) Directive 98/44/EC of the European Parliament and of the Council of the EU on the legal protection of biotechnological inventions, Official Journal L 213, 30/7/98, pp. 13-21.
26. EUROPEAN PARLIAMENT, TEMPORARY COMMITTEE ON HUMAN GENETICS AND OTHER NEW TECHNOLOGIES IN MODERN MEDICINE (2001b) Report on the Ethical, Legal Economic and Social Implications of Human Genetics, Final A5-0391/2001, European Parliament Session Document, Brussels.
27. EUROPEAN PARLIAMENT, TEMPORARY COMMITTEE ON HUMAN GENETICS AND OTHER NEW TECHNOLOGIES IN MODERN MEDICINE (2001c) Factsheet on the Temporary Committee on Human Genetics and Other New Technologies in Modern Medicine, Brussels.
28. FUNTOWICZ, S., SHEPHERD, L, WILKINSON, D. and RAVETZ, J. (2000) Science and governance in the EU: a contribution to the debate, Science and Public Policy, 27, pp. 327-336.
29. HEALTH AND CONSUMER PROTECTION DG (2000) Commission takes initiative to restore confidence in GMO approval process, Press Release, 13 July, Brussels.
30. HELLER, M.A. and EISENBERG, R.S. (1998) Can patents deter innovation? The anticommons in biomedical research, Science, 280, pp. 698-701.
31. HILL, S. and TURPIN, T. (1994) Academic research culture in collision, Science as Culture, 4, pp. 327-362.
32. HOOGHE, L. and MARKS, G. (2001) Multi-level Governance and European Integration (Lanham, AM, Rowman and Littlefield).
33. HOSSEINI, M,, NAGELS, K., FURTH, J. and MÜLLER, M. (2001) Driving bio, deals, Scrip Magazine, December, pp. 22-24.
34. JASANOFF, S. (2000) Commentary: between risk and precaution-reassessing the future of GM crops, Journal of Risk Research, 3, pp. 277-282.
35. JORDAN, A. (1998) The politics of multi-level governance, Environment, 40, pp. 14-20 and 39-45.
36. JORDAN, A. and O'RIORDEN, T. (1994) The Precautionary Principle in UK Environment Law and Policy (Norwich, CSERGE).
37. Lancet (2001) Spain closes the door on embryonic stem cell research, Lancet, 20 October.
38. LEVIDOW, L. (1999) Britain's biotechnology controversy: elusive science, contested expertise, New Genetics and Society, 18, pp. 47-64.
39. LEVIDOW, L. and CARR, S. (2000) UK: precautionary commercialisation, Journal of Risk Research, 3, pp. 261-270.
40. LEVIDOW, L., CARR, S. and WIELD D. (2000) Genetically modified crops in the EU: regulatory conflicts as precautionary opportunities, Journal of Risk Research, 3, pp. 189-208.
41. LEWIS, G. and ABRAHAM, J. (1998) Making harmonisation work: the politics of scientific expertise in European medicines regulation, Science and Public Policy 25, pp. 165-177.
42. MARKS, G. and MCADAM, D. (1996) Social movements and the changing structure of political opportunity in the European Community, West European Politics, 19, pp. 249-278.
43. MARKS, G., SCHARPF, F., SCHMITTER, P. and STREECK, W. (1996) Governance in the Emerging European Union (London, Sage).
44. MCNALLY, R. and WHEALE, P.R. (1998) The consequences of modern genetic engineering: patents, nomads and the Bio-industrial Complex, in: P. WHEALE, R. VON SCHOMBERG and P. GLASNER (Eds) The Social Management of Genetic Engineering, pp. 303-330 (Aldershot, Ashgate).
45. PAULA, L. (2001) Ethics: the key to public acceptance of biotechnology?, Biotechnology and Development Monitor, No. 47, September, pp. 22-23.
46. RAPPERT, B. (1995) Shifting notions of accountability in public and private sector research in the UK: some central concerns, Science and Public Policy, 22, pp. 383-390.
47. RESEARCH EUROPE (2001a) A difference of opinion, Editorial, Research Europe, 15 November, p. 8.
48. RESEARCH EUROPE (2001b) Swiss allow embryo stem cell project, Research Europe, 4 October, p. 7.
49. RITTER, K. (2001) Swedish Council supports therapeutic cloning, Nando Times, 4 December.
50. RONIT, K. and SCHNEIDER, V. (1999) Global governance through private organisations, Governance, 12, pp. 243-266.
51. Scrip (2001) Dutch take middle path on stem cells, Scrip, 2691, 31 October, p. 2.
52. SCULLY, R. (1997) The EP and the co-decision procedure: a re-assessment, Journal of Legislative Studies, 3, pp. 58-73.
53. SPALLONE, P. and WILKIE, T. (1999) Social, ethical and public policy implications of advances in the biomedical sciences: the Wellcome Trust's initiative on pharmacogenetics, Paper presented to the European Workshop on Legal, Regulatory and Ethical Aspects in Pharmacogenetics, 12 November, Berlin.
54. TSEBELIS, G. and GARRETT, G. (2000) Legislative politics in the European Union, European Union Politics 1, pp. 9-36.
55. UNESCO (1997a) Universal Declaration on the Human Genome and Human Rights, adopted by the General Conference of UNESCO at its 29th Session, 11 November.
56. UNESCO (1997b) Why do we need a declaration on the human genome?, General Conference 1977, available at .
57. UNESCO (1997c) Resolution on the implementation of the Universal Declaration on the Human Genome and Human Rights, Resolution 29 C/17, 29th Session, 11 November.
58. WALLACE, H. and WALLACE, W. (1996) Policy Making in the European Union (Oxford, Oxford University Press).
59. WHEALE, P. (1999) The social management of modern biotechnology and the new industrial divide, New Genetics and Society, 18, pp. 23-46.
60. WHEALE, P. and MCNALLY, R. (1998) The social management of genetic engineering: an introduction, in: P. WHEALE, R. VON SCHOMBERG and P. GLASNER (Eds) The Social Management of Genetic Engineering, pp. 1-28 (Aldershot, Ashgate).